Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
about
Antifungal Prophylaxis in Immunocompromised PatientsAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsInfectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.
P2860
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tolerability and outcome of on ...... ith graft-versus-host disease.
@ast
Tolerability and outcome of on ...... ith graft-versus-host disease.
@en
type
label
Tolerability and outcome of on ...... ith graft-versus-host disease.
@ast
Tolerability and outcome of on ...... ith graft-versus-host disease.
@en
prefLabel
Tolerability and outcome of on ...... ith graft-versus-host disease.
@ast
Tolerability and outcome of on ...... ith graft-versus-host disease.
@en
P2093
P2860
P356
P1476
Tolerability and outcome of on ...... ith graft-versus-host disease.
@en
P2093
Dave Henry
Dennis Grauer
Huong Luu Tran
Joseph McGuirk
Michelle Rockey
Omar Aljitawi
Siddhartha Ganguly
Sunil Abhyankar
Zahra Mahmoudjafari
P2860
P304
P356
10.1177/1078155214560920
P50
P577
2014-12-03T00:00:00Z